Home

Brian T Gladden

CIK 1435432 · EVP & CFO · last filed 2026-06-15

Brian T Gladden is an EVP & CFO who has filed 52 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider bought $100.0K of XRAY on Jun 15, 2026. Across all open-market trades the lifetime net is −$8.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $505.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$505.25M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$8.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XRAY Director 61,848 $13.71 $848.3K $100.0K 13 2026-06-15
MDLZ EVP & CFO 194,565 $63.08 $12.27M $0 6 2018-02-26
DELL Senior Vice President 1,204,688 $408.51 $492.13M -$8.84M 32 2013-08-16

Recent Filings

52 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-15 XRAY Buy (P) +9,985 $100.0K EDGAR
2026-06-05 XRAY Grant (A) +22,822 $0 EDGAR
2026-01-13 XRAY Grant (A) +314 $0 EDGAR
2025-10-15 XRAY Grant (A) +286 $0 EDGAR
2025-07-15 XRAY Grant (A) +222 $0 EDGAR
2025-05-27 XRAY Grant (A) +13,880 $0 EDGAR
2025-04-15 XRAY Grant (A) +87 $0 EDGAR
2025-01-14 XRAY Grant (A) +119 $0 EDGAR
2024-10-15 XRAY Grant (A) +83 $0 EDGAR
2024-07-15 XRAY Grant (A) +89 $0 EDGAR
Showing 1–10 of 52
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.